Jobs / United States / Pfizer INC
Senior Manager, HTA, Value and Evidence (HV&E), Genitourinary Cancer
Pfizer INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Pfizer INC paid sponsored hires in similar roles3 certified filings for “SENIOR MANAGER, STATISTICAL PROGRAMMING” (Statisticians) in CA: $171k–$214k, median $208k. Most were filed at wage level IV (67%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines. The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making. ROLE SUMMARY The HTA, Value & Evidence Senior Manager is responsible for development and execution of high-quality HV&E strategic efforts to support optimal access and reimbursement for treatments in Oncology. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of Oncology medicines. This position will be part of Pfizer’s dynamic HTA Value & Evidence team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to the GU Cancer Portfolio. This position will be working closely with the Oncology cross-functional teams (e.g., access, medical, clinical, commercial, etc.) and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and society in general. This position will function in a closely aligned fashion with the Global Access Strategy and Pricing (GASP) team to ensure there is a single and coordinated view on strategy and project execution. This position will function with a ‘OnePfizer’ mindset and will work in a closely aligned fashion with Oncology cross-functional team members to ensure there is a single and coordinated view on strategy and delivery from the team to the Oncology business. ROLE RESPONSIBILITIES • Support the development of the Global HTA Value & Evidence Strategy in close partnership with cross-functional teams • Manage execution of clinically relevant and scientifically valid Value & Evidence studies and projects (including non-interventional studies, registries, etc.) in alignment with the global Value & Evidence Strategy to demonstrate the value proposition catered to diverse stakeholders (regulators, payers, patients, physicians, and policy makers) • Lead updates of tools including global value dossiers (GVDs), economic models, and innovative tools to support value proposition • Develop real world evidence generation strategies and execute studies to support brand differentiation and value proposition • Support the coordination of input from local country/regional Access & Value teams on evidence needs and ensure that input is appropriately incorporated to support demonstration of product value and optimize patient access • Lead the development of data dissemination plans and communicate, in a timely manner, evidence generated for various stakeholders via publications and conference presentations BASIC QUALIFICATIONS Candidate demonstrates a breadth of diverse capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of external stakeholders to achieve meaningful outcomes and create business impact. • Graduate degree required (e.g., MSc, MPH, PhD, DrPH) in HEOR-relevant field such as health services research, health economics, epidemiology, pharmacy administration/pharmaceutical policy, or other research-focused public health field. • 2+ years of experience with MSc/MPH/MBA degree; 1+ year of experience with PharmD/PhD/DrPH in HEOR or releva